Review

ar v7 (Cell Signaling Technology Inc)

Cell Signaling Technology Inc is a verified supplier

Cell Signaling Technology Inc manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Cell Signaling Technology Inc ar v7

Ferroptosis agonist reverses enzalutamide resistance induced by high RORC expression. A . Normal C4-2B cells morphology and enzalutamide half inhibition rate. B . The half inhibition rate and cells morphology of enzalutamide on oe RORC /C4-2B cells. C . The culture of enzalutamide-resistant C4-2B cells (C4-2B/ENZR). D . The half inhibition rate and cells morphology of enzalutamide-resistant C4-2B cells (C4-2B/ENZR). E . The expression of RORC in C4-2B/ENZR cells was detected by western blot, C4-2B/ENZR vs C4-2B: *** P -value ≤ 0.001. F . Assessment of the inhibitory effect of enzalutamide (ENZ) on C4-2B cell proliferation. G . Evaluation of the inhibitory efficacy of erastin (ERA) on the proliferative capacity of C4-2B cells. H . Cell counting telomere fluorescence assay was used to detect the proliferation ability of oe RORC /C4-2B cells. I . The effect of oe RORC /C4-2B cells proliferation was detected by plate cloning assay. J . Western blot was used to detect the expression of apoptosis and proliferation proteins. K . Western blot was used to detect the expression of AR, <t>AR-V7,</t> and ROR-γ in oe RORC /C4-2B cells. L . Western blot was used to detect the expression of ferroptosis protein. M . Cell counting assay was used to detect the proliferation ability of oe RORC /C4-2B cells. N . Visualization of plate cloning experiment histogram. O . Protein expression quantification of apoptosis and proliferation markers. P . Quantification of AR, AR-V7, and ROR-γ protein expression levels. Q . Quantification of ferroptosis protein expression levels. R . GSH content in oe RORC /C4-2B cells. S. MDA content in oe RORC /C4-2B cells. T . Fe 2+ content in oe RORC /C4-2B cells. U . ROS fluorescence experiment histogram visualization. V . ROS fluorescence assay was used to detect the content of ROS in oe RORC /C4-2B cells. W . JC-1 assay was used to detect the changes of mitochondrial membrane potential in oe RORC /C4-2B cells. X . JC-1 experiment histogram visualization. * P -value ≤ 0.1; ** P -value ≤ 0.01; *** P -value ≤ 0.001; **** P -value ≤ 0.0001. NS no significance

Ar V7, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 25 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ar v7/product/Cell Signaling Technology Inc
Average 94 stars, based on 25 article reviews

ar v7 - by Bioz Stars, 2026-06

94/100 stars

Images

1) Product Images from "Inhibition of the RORC/GPX4 mediated ferroptosis regulatory axis suppresses tumor growth and alleviates enzalutamide resistance in prostate cancer"

Article Title: Inhibition of the RORC/GPX4 mediated ferroptosis regulatory axis suppresses tumor growth and alleviates enzalutamide resistance in prostate cancer

Journal: Cellular & Molecular Biology Letters

doi: 10.1186/s11658-025-00846-z

Figure Legend Snippet: Ferroptosis agonist reverses enzalutamide resistance induced by high RORC expression. A . Normal C4-2B cells morphology and enzalutamide half inhibition rate. B . The half inhibition rate and cells morphology of enzalutamide on oe RORC /C4-2B cells. C . The culture of enzalutamide-resistant C4-2B cells (C4-2B/ENZR). D . The half inhibition rate and cells morphology of enzalutamide-resistant C4-2B cells (C4-2B/ENZR). E . The expression of RORC in C4-2B/ENZR cells was detected by western blot, C4-2B/ENZR vs C4-2B: *** P -value ≤ 0.001. F . Assessment of the inhibitory effect of enzalutamide (ENZ) on C4-2B cell proliferation. G . Evaluation of the inhibitory efficacy of erastin (ERA) on the proliferative capacity of C4-2B cells. H . Cell counting telomere fluorescence assay was used to detect the proliferation ability of oe RORC /C4-2B cells. I . The effect of oe RORC /C4-2B cells proliferation was detected by plate cloning assay. J . Western blot was used to detect the expression of apoptosis and proliferation proteins. K . Western blot was used to detect the expression of AR, AR-V7, and ROR-γ in oe RORC /C4-2B cells. L . Western blot was used to detect the expression of ferroptosis protein. M . Cell counting assay was used to detect the proliferation ability of oe RORC /C4-2B cells. N . Visualization of plate cloning experiment histogram. O . Protein expression quantification of apoptosis and proliferation markers. P . Quantification of AR, AR-V7, and ROR-γ protein expression levels. Q . Quantification of ferroptosis protein expression levels. R . GSH content in oe RORC /C4-2B cells. S. MDA content in oe RORC /C4-2B cells. T . Fe 2+ content in oe RORC /C4-2B cells. U . ROS fluorescence experiment histogram visualization. V . ROS fluorescence assay was used to detect the content of ROS in oe RORC /C4-2B cells. W . JC-1 assay was used to detect the changes of mitochondrial membrane potential in oe RORC /C4-2B cells. X . JC-1 experiment histogram visualization. * P -value ≤ 0.1; ** P -value ≤ 0.01; *** P -value ≤ 0.001; **** P -value ≤ 0.0001. NS no significance

Techniques Used: Expressing, Inhibition, Western Blot, Cell Counting, Fluorescence, Cloning, Membrane

Ilicicolin A inhibited the proliferation of CRPC cells through induction of ferroptosis. A . Expression levels of AR, AR-V7, and ROR-γ were detected by western blot. B . Western blot assay was used to evaluate the effect of ilicicolin A on ferroptosis-related proteins. C . Measurement of MDA content in 22Rv1 cells. D . Measurement of MDA content in C4-2B cells. E . Measurement of GSH content in 22Rv1 cells. F . Measurement of GSH content in C4-2B cells. G . Measurement of Fe 2+ content in 22Rv1 cells. H . Measurement of Fe 2+ content in C4-2B cells. I . Fe 2+ levels in CRPC cells were assessed using the ferroOrange fluorescence assay. J . Histogram visualization of the ferroOrange fluorescence experiment. * P -value ≤ 0.1; ** P -value ≤ 0.01; *** P -value ≤ 0.001; **** P -value ≤ 0.0001. NS no significance

Figure Legend Snippet: Ilicicolin A inhibited the proliferation of CRPC cells through induction of ferroptosis. A . Expression levels of AR, AR-V7, and ROR-γ were detected by western blot. B . Western blot assay was used to evaluate the effect of ilicicolin A on ferroptosis-related proteins. C . Measurement of MDA content in 22Rv1 cells. D . Measurement of MDA content in C4-2B cells. E . Measurement of GSH content in 22Rv1 cells. F . Measurement of GSH content in C4-2B cells. G . Measurement of Fe 2+ content in 22Rv1 cells. H . Measurement of Fe 2+ content in C4-2B cells. I . Fe 2+ levels in CRPC cells were assessed using the ferroOrange fluorescence assay. J . Histogram visualization of the ferroOrange fluorescence experiment. * P -value ≤ 0.1; ** P -value ≤ 0.01; *** P -value ≤ 0.001; **** P -value ≤ 0.0001. NS no significance

Techniques Used: Expressing, Western Blot, Fluorescence

Ilicicolin A suppresses tumor growth in vivo. A . General information of in vivo experiments on the detection of CRPC proliferation ability by ilicicolin A. B . Effect of ilicicolin A on body weight of nude mice. C . The size of tumor volume in nude mice was measured and recorded in vivo. D . The results of subcutaneous tumor formation in nude mice. E . The heart, lung, spleen, liver, and kidney were observed by HE staining. F . Immunohistochemistry was used to detect the expression of ferroptosis antibody, AR, AR-V7, and ROR-γ. G . Western blot was used to detect the expression of apoptosis and proliferation proteins. H . Western blot was used to detect the expression of AR, AR-V7, and ROR-γ. I . Western blot was used to detect the expression of ferroptosis protein. * P -value ≤ 0.1; ** P -value ≤ 0.01; *** P -value ≤ 0.001; **** P -value ≤ 0.0001. NS no significance

Figure Legend Snippet: Ilicicolin A suppresses tumor growth in vivo. A . General information of in vivo experiments on the detection of CRPC proliferation ability by ilicicolin A. B . Effect of ilicicolin A on body weight of nude mice. C . The size of tumor volume in nude mice was measured and recorded in vivo. D . The results of subcutaneous tumor formation in nude mice. E . The heart, lung, spleen, liver, and kidney were observed by HE staining. F . Immunohistochemistry was used to detect the expression of ferroptosis antibody, AR, AR-V7, and ROR-γ. G . Western blot was used to detect the expression of apoptosis and proliferation proteins. H . Western blot was used to detect the expression of AR, AR-V7, and ROR-γ. I . Western blot was used to detect the expression of ferroptosis protein. * P -value ≤ 0.1; ** P -value ≤ 0.01; *** P -value ≤ 0.001; **** P -value ≤ 0.0001. NS no significance

Techniques Used: In Vivo, Staining, Immunohistochemistry, Expressing, Western Blot

Ilicicolin A induces ferroptosis and regresses tumor growth of CRPC in vivo. A . General information on the in vivo experiment of ilicicolin A enhancing the sensitivity of CRPC to enzalutamide. B . Effects of ilicicolin A and Enzalutamide on body weight of nude mice. C . The size of tumor volume in nude mice was measured and recorded in vivo by ilicicolin A and enzalutamide. D . The results of subcutaneous tumor formation in nude mice. E . The heart, lung, spleen, liver, and kidney were observed by HE staining experimental. F . Immunohistochemistry was used to detect the expression of ferroptosis antibody, AR, AR-V7, and ROR-γ. G . Western blot was used to detect the expression level of apoptosis and proliferation proteins. H . Western blot was used to detect the expression level of AR, AR-V7, and ROR-γ. I . Western blot was used to detect the expression of ferroptosis protein. * P -value ≤ 0.1; ** P -value ≤ 0.01; *** P -value ≤ 0.001; **** P -value ≤ 0.0001. NS no significance

Figure Legend Snippet: Ilicicolin A induces ferroptosis and regresses tumor growth of CRPC in vivo. A . General information on the in vivo experiment of ilicicolin A enhancing the sensitivity of CRPC to enzalutamide. B . Effects of ilicicolin A and Enzalutamide on body weight of nude mice. C . The size of tumor volume in nude mice was measured and recorded in vivo by ilicicolin A and enzalutamide. D . The results of subcutaneous tumor formation in nude mice. E . The heart, lung, spleen, liver, and kidney were observed by HE staining experimental. F . Immunohistochemistry was used to detect the expression of ferroptosis antibody, AR, AR-V7, and ROR-γ. G . Western blot was used to detect the expression level of apoptosis and proliferation proteins. H . Western blot was used to detect the expression level of AR, AR-V7, and ROR-γ. I . Western blot was used to detect the expression of ferroptosis protein. * P -value ≤ 0.1; ** P -value ≤ 0.01; *** P -value ≤ 0.001; **** P -value ≤ 0.0001. NS no significance

Techniques Used: In Vivo, Staining, Immunohistochemistry, Expressing, Western Blot

Ilicicolin A alleviates enzalutamide resistance by RORC/GPX4 axis of CRPC in vivo. A . General information on the in vivo experiment of ilicicolin A enhancing the sensitivity of CRPC to enzalutamide. B . Effects of ilicicolin A, enzalutamide, and erastin on body weight of nude mice. C . In vivo measurement and recording of the tumor volume of ilicicolin A, enzalutamide, and erastin in nude mice. D . The results of subcutaneous tumor formation in nude mice. E . The heart, lung, spleen, liver, and kidney were observed by HE staining. F . Immunohistochemistry was used to detect the expression of ferroptosis antibody, AR, AR-V7, and ROR-γ. G . Western blot was used to detect the expression of apoptosis and proliferation proteins. H . Western blot was used to detect the expression of AR, AR-V7, and ROR-γ. I . Western blot was used to detect the expression of ferroptosis protein. * P -value ≤ 0.1; ** P -value ≤ 0.01; *** P -value ≤ 0.001; **** P -value ≤ 0.0001. NS no significance

Figure Legend Snippet: Ilicicolin A alleviates enzalutamide resistance by RORC/GPX4 axis of CRPC in vivo. A . General information on the in vivo experiment of ilicicolin A enhancing the sensitivity of CRPC to enzalutamide. B . Effects of ilicicolin A, enzalutamide, and erastin on body weight of nude mice. C . In vivo measurement and recording of the tumor volume of ilicicolin A, enzalutamide, and erastin in nude mice. D . The results of subcutaneous tumor formation in nude mice. E . The heart, lung, spleen, liver, and kidney were observed by HE staining. F . Immunohistochemistry was used to detect the expression of ferroptosis antibody, AR, AR-V7, and ROR-γ. G . Western blot was used to detect the expression of apoptosis and proliferation proteins. H . Western blot was used to detect the expression of AR, AR-V7, and ROR-γ. I . Western blot was used to detect the expression of ferroptosis protein. * P -value ≤ 0.1; ** P -value ≤ 0.01; *** P -value ≤ 0.001; **** P -value ≤ 0.0001. NS no significance

Techniques Used: In Vivo, Staining, Immunohistochemistry, Expressing, Western Blot

Image Search Results

Journal: Cellular & Molecular Biology Letters

Article Title: Inhibition of the RORC/GPX4 mediated ferroptosis regulatory axis suppresses tumor growth and alleviates enzalutamide resistance in prostate cancer

doi: 10.1186/s11658-025-00846-z

Figure Lengend Snippet: Ferroptosis agonist reverses enzalutamide resistance induced by high RORC expression. A . Normal C4-2B cells morphology and enzalutamide half inhibition rate. B . The half inhibition rate and cells morphology of enzalutamide on oe RORC /C4-2B cells. C . The culture of enzalutamide-resistant C4-2B cells (C4-2B/ENZR). D . The half inhibition rate and cells morphology of enzalutamide-resistant C4-2B cells (C4-2B/ENZR). E . The expression of RORC in C4-2B/ENZR cells was detected by western blot, C4-2B/ENZR vs C4-2B: *** P -value ≤ 0.001. F . Assessment of the inhibitory effect of enzalutamide (ENZ) on C4-2B cell proliferation. G . Evaluation of the inhibitory efficacy of erastin (ERA) on the proliferative capacity of C4-2B cells. H . Cell counting telomere fluorescence assay was used to detect the proliferation ability of oe RORC /C4-2B cells. I . The effect of oe RORC /C4-2B cells proliferation was detected by plate cloning assay. J . Western blot was used to detect the expression of apoptosis and proliferation proteins. K . Western blot was used to detect the expression of AR, AR-V7, and ROR-γ in oe RORC /C4-2B cells. L . Western blot was used to detect the expression of ferroptosis protein. M . Cell counting assay was used to detect the proliferation ability of oe RORC /C4-2B cells. N . Visualization of plate cloning experiment histogram. O . Protein expression quantification of apoptosis and proliferation markers. P . Quantification of AR, AR-V7, and ROR-γ protein expression levels. Q . Quantification of ferroptosis protein expression levels. R . GSH content in oe RORC /C4-2B cells. S. MDA content in oe RORC /C4-2B cells. T . Fe 2+ content in oe RORC /C4-2B cells. U . ROS fluorescence experiment histogram visualization. V . ROS fluorescence assay was used to detect the content of ROS in oe RORC /C4-2B cells. W . JC-1 assay was used to detect the changes of mitochondrial membrane potential in oe RORC /C4-2B cells. X . JC-1 experiment histogram visualization. * P -value ≤ 0.1; ** P -value ≤ 0.01; *** P -value ≤ 0.001; **** P -value ≤ 0.0001. NS no significance

Article Snippet: Experimental materials are listed below: N-cadherin (66219–1-Ig, Proteintech), vimentin (E-AB-18212, Proteintech), Snail (26183–1-AP, Proteintech), MMP2 (E-AB-40409, Proteintech), Parp-1 (13371–1-AP, Proteintech), AR (22089–1-AP, Proteintech), AR-V7 (68492S, Cell Signaling Technology), RORC (PA5-23148, Thermo Scientific), E-cadherin (20874–1-AP, Proteintech), c-Myc (10828–1-AP, Proteintech), cyclin D1 (26939–1-AP, Proteintech), cleaved caspase 7 (9491S, Cell Signaling Technology), GPX4 (67763–1-Ig, Proteintech), SLC7A11 (26864–1-AP, Proteintech), FTH1 (10727–1-AP, Proteintech), and GAPDH (60004–1-Ig, Proteintech).

Techniques: Expressing, Inhibition, Western Blot, Cell Counting, Fluorescence, Cloning, Membrane

Journal: Cellular & Molecular Biology Letters

Article Title: Inhibition of the RORC/GPX4 mediated ferroptosis regulatory axis suppresses tumor growth and alleviates enzalutamide resistance in prostate cancer

doi: 10.1186/s11658-025-00846-z

Figure Lengend Snippet: Ilicicolin A inhibited the proliferation of CRPC cells through induction of ferroptosis. A . Expression levels of AR, AR-V7, and ROR-γ were detected by western blot. B . Western blot assay was used to evaluate the effect of ilicicolin A on ferroptosis-related proteins. C . Measurement of MDA content in 22Rv1 cells. D . Measurement of MDA content in C4-2B cells. E . Measurement of GSH content in 22Rv1 cells. F . Measurement of GSH content in C4-2B cells. G . Measurement of Fe 2+ content in 22Rv1 cells. H . Measurement of Fe 2+ content in C4-2B cells. I . Fe 2+ levels in CRPC cells were assessed using the ferroOrange fluorescence assay. J . Histogram visualization of the ferroOrange fluorescence experiment. * P -value ≤ 0.1; ** P -value ≤ 0.01; *** P -value ≤ 0.001; **** P -value ≤ 0.0001. NS no significance

Techniques: Expressing, Western Blot, Fluorescence

Journal: Cellular & Molecular Biology Letters

Article Title: Inhibition of the RORC/GPX4 mediated ferroptosis regulatory axis suppresses tumor growth and alleviates enzalutamide resistance in prostate cancer

doi: 10.1186/s11658-025-00846-z

Figure Lengend Snippet: Ilicicolin A suppresses tumor growth in vivo. A . General information of in vivo experiments on the detection of CRPC proliferation ability by ilicicolin A. B . Effect of ilicicolin A on body weight of nude mice. C . The size of tumor volume in nude mice was measured and recorded in vivo. D . The results of subcutaneous tumor formation in nude mice. E . The heart, lung, spleen, liver, and kidney were observed by HE staining. F . Immunohistochemistry was used to detect the expression of ferroptosis antibody, AR, AR-V7, and ROR-γ. G . Western blot was used to detect the expression of apoptosis and proliferation proteins. H . Western blot was used to detect the expression of AR, AR-V7, and ROR-γ. I . Western blot was used to detect the expression of ferroptosis protein. * P -value ≤ 0.1; ** P -value ≤ 0.01; *** P -value ≤ 0.001; **** P -value ≤ 0.0001. NS no significance

Techniques: In Vivo, Staining, Immunohistochemistry, Expressing, Western Blot

Journal: Cellular & Molecular Biology Letters

Article Title: Inhibition of the RORC/GPX4 mediated ferroptosis regulatory axis suppresses tumor growth and alleviates enzalutamide resistance in prostate cancer

doi: 10.1186/s11658-025-00846-z

Figure Lengend Snippet: Ilicicolin A induces ferroptosis and regresses tumor growth of CRPC in vivo. A . General information on the in vivo experiment of ilicicolin A enhancing the sensitivity of CRPC to enzalutamide. B . Effects of ilicicolin A and Enzalutamide on body weight of nude mice. C . The size of tumor volume in nude mice was measured and recorded in vivo by ilicicolin A and enzalutamide. D . The results of subcutaneous tumor formation in nude mice. E . The heart, lung, spleen, liver, and kidney were observed by HE staining experimental. F . Immunohistochemistry was used to detect the expression of ferroptosis antibody, AR, AR-V7, and ROR-γ. G . Western blot was used to detect the expression level of apoptosis and proliferation proteins. H . Western blot was used to detect the expression level of AR, AR-V7, and ROR-γ. I . Western blot was used to detect the expression of ferroptosis protein. * P -value ≤ 0.1; ** P -value ≤ 0.01; *** P -value ≤ 0.001; **** P -value ≤ 0.0001. NS no significance

Techniques: In Vivo, Staining, Immunohistochemistry, Expressing, Western Blot

Journal: Cellular & Molecular Biology Letters

Article Title: Inhibition of the RORC/GPX4 mediated ferroptosis regulatory axis suppresses tumor growth and alleviates enzalutamide resistance in prostate cancer

doi: 10.1186/s11658-025-00846-z

Figure Lengend Snippet: Ilicicolin A alleviates enzalutamide resistance by RORC/GPX4 axis of CRPC in vivo. A . General information on the in vivo experiment of ilicicolin A enhancing the sensitivity of CRPC to enzalutamide. B . Effects of ilicicolin A, enzalutamide, and erastin on body weight of nude mice. C . In vivo measurement and recording of the tumor volume of ilicicolin A, enzalutamide, and erastin in nude mice. D . The results of subcutaneous tumor formation in nude mice. E . The heart, lung, spleen, liver, and kidney were observed by HE staining. F . Immunohistochemistry was used to detect the expression of ferroptosis antibody, AR, AR-V7, and ROR-γ. G . Western blot was used to detect the expression of apoptosis and proliferation proteins. H . Western blot was used to detect the expression of AR, AR-V7, and ROR-γ. I . Western blot was used to detect the expression of ferroptosis protein. * P -value ≤ 0.1; ** P -value ≤ 0.01; *** P -value ≤ 0.001; **** P -value ≤ 0.0001. NS no significance

Techniques: In Vivo, Staining, Immunohistochemistry, Expressing, Western Blot

Review

Structured Review

Images

1) Product Images from "Inhibition of the RORC/GPX4 mediated ferroptosis regulatory axis suppresses tumor growth and alleviates enzalutamide resistance in prostate cancer"

Similar Products

Image Search Results